ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
94,496.72
1.52%
S&P 500
5,987.37
0.30%
Dow Jones
44,736.57
0.99%
US Dollar vs Yen
154.122
-0.12%
Brent Oil
72.575
-0.04%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Provectus Biopharmaceuticals Inc (QB) (PVCT)

  7. Provectus Biopharmaceuticals Inc (QB) (PVCT) ニュース

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

Provectus Biopharmaceuticals Inc (QB)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:PVCT
日付受信時刻ニュースソース見出しコード企業名
2024/11/2607 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/11/1422 : 00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/11/1305 : 34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/10/1801 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/10/0109 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/10/0109 : 01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/10/0108 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/10/0107 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/10/0107 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/09/2106 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/3022 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/2800 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/2004 : 06Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/1508 : 23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/1508 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/1402 : 21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/1004 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/08/0606 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/07/2406 : 20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/07/2304 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/07/2002 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/07/1805 : 07Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/07/1804 : 50Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/06/2022 : 30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/06/2019 : 03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/06/1806 : 58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/05/2906 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/05/1503 : 43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/05/1402 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
2024/05/0923 : 54Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Showing the most relevant articles for your search:USOTC:PVCT

最近閲覧した銘柄

NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
FX
USDEUR
US Dollar vs Euro
AMEX
XLF
Financial Select Sector
CCOM
US30
US 30
NASDAQ
GOOGL
Alphabet
NYSE
JPM
JP Morgan Chase
USOTC
BNPQY
BNP Paribas (QX)
FX
USDJPY
US Dollar vs Yen
COIN
XRPUSD
Ripple
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
FX
USDGBP
US Dollar vs Sterling
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有